US Archives - Page 6 of 137 - European Medical Journal

Teen and adult patients practicing gentle acne skincare with cleanser, moisturizer, and sunscreen

Skincare Awareness Linked with Milder Acne

Patients with acne who understand and routinely use basic skincare report milder disease in this cross-sectional study.

Laboratory technician conducting AATD diagnostic test using genotyping and sequencing technology.

CHEST 2025: New Algorithm Enhances AATD Diagnosis Accuracy

Alpha-1 antitrypsin deficiency (AATD) remains a frequently underdiagnosed condition that predisposes individuals to chronic lung and liver diseases.

IDWeek 2025: Zoster Vaccine Linked to Lower Cardiovascular, Dementia Risk

Prior zoster vaccination reduces risks of cardiovascular events, dementia, and death after shingles infection, new IDWeek 2025 data show.

Older adult medication management concept highlighting tramadol and antidepressants seizure risk.

Tramadol And Antidepressants Raise Seizure Risk

Tramadol with CYP2D6-inhibiting antidepressants was associated with higher seizure rates in nursing home residents in Medicare.

clinician reviews neurocognitive testing results for central nervous system cancer

Neurocognitive Functioning in CNS Cancer Declines Significantly

Neurocognitive functioning declines across central nervous system cancers, shaped by tumor location and interacting treatment effects.

CT scan concept of lung cancer with EGFR mutation and chemotherapy treatment

Osimertinib Plus Chemo Extends Survival in EGFR-Mutated NSCLC

Osimertinib plus chemotherapy improved overall survival versus monotherapy in EGFR-mutated advanced NSCLC in a Phase III trial.

IDWeek 2025: C. diff Deaths Show Stark Demographic Gaps

A 25-year USA study finds C. diff deaths highest among White people, women, and city residents, though overall mortality has fallen since 2015.

Elderly woman using a nebulizer for respiratory treatment while holding hands with a healthcare provider

CHEST 2025: Nerandomilast Shows Promise in Slowing IPF Decline

In a Phase III trial, the addition of nerandomilast demonstrated a promising ability to slow disease progression in patients with idiopathic pulmonary fibrosis (IPF).

Unmet Need in 1L HR+/HER2- Advanced Breast Cancer

Explore why outcomes often decline after first-line endocrine therapy in HR+/HER2- advanced breast cancer and how emerging treatments…

Real-World Insights on High-Dose Flu Vaccination

This infographic summarizes findings from FLUNITY-HD, the largest ever individually randomized influenza vaccine effectiveness trial…